Grail工商信息_电话_地址_信用信息_财务信息

公司简介

GRAIL is a life sciences company that aims to detect cancer early when it can be cured.They uses the power of high-intensity sequencing, population-scale clinical trials, and state of the art computer science and data science to enhance the scientific understanding of cancer biology. They develop blood tests and blood screen for early-stage cancer detection.

主要成员

Jeff Dean、Jay Flatley、Jeff Bird、Jeffrey Huber、Donald Berry、Hal Barron、Richard Klausner、William Rastetter、Levi Garraway、Brian Druker、Charles Swanton、Jose Baselga、Timothy Church、Mostafa Ronaghi、Richard Klausner、Robert Nelsen

产品/服务

肿瘤基因组

The GRAIL approach

By combining high-intensity sequencing with modern data science and technology, Grail finds cancer as soon as possible in asymptomatic conditions

融资信息

融资轮次	融资日期	投资方	融资额度
A轮	2016-06	ARCH Venture Partners、Sutter Hill Ventures、Bezos Expeditions、Bill Gates、Illumina	$100M
B轮	2017-11	ARCH Venture Partners、Johnson & Johnson Development Corporation	$1200M
C轮	2018-05	汇桥资本、通和毓承、高瓴资本、蓝池资本、招商证券国际、CRF Investment、黄浦江资本、工银国际、红杉资本中国、药明明码等	$300M
D轮	2020-05	Public Sector Pension Investment Board, Canada Pension Plan Investment Board, Illumina	3.9亿美元
并购	2020-10	Illumina	80亿美元

关联公司